XOMA Royalty (XOMA) Dividends Paid - Common (2021 - 2026)
XOMA Royalty (XOMA) reported Dividends Paid - Common of $1.4 million for Q1 2026, up 4.09% on a YoY basis from $1.4 million in Q1 2025, and up 4.09% sequentially from $1.4 million in Q4 2025.
XOMA Royalty (XOMA) Dividends Paid - Common (2021 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 6 years of Dividends Paid - Common data on file, last reported at $1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Dividends Paid - Common rose 4.09% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.5 million (up 1.02% YoY), and the FY2025 full-year result was $5.5 million, changed 0.0% from the prior year.
- Dividends Paid - Common advanced to $1.4 million in Q1 2026, from $1.4 million in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $1.4 million in Q1 2026 to a low of $1.4 million in Q1 2022.
- A 5-year average of $1.4 million and a median of $1.4 million in 2022 frame the typical range for Dividends Paid - Common.
- Across the five-year window, Dividends Paid - Common declined 3.93% in 2022 and increased 4.09% in 2026, its largest moves.
- Tracing XOMA's Dividends Paid - Common over 5 years: stood at $1.4 million in 2022, then changed by 0.0% to $1.4 million in 2023, then changed by 0.0% to $1.4 million in 2024, then changed by 0.0% to $1.4 million in 2025, then climbed by 4.09% to $1.4 million in 2026.
- Business Quant data shows XOMA's Dividends Paid - Common at $1.4 million in Q1 2026, $1.4 million in Q4 2025, and $1.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 97.80 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.42 Mn |
| Mar 31, 2026 | 1.42 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Dec 31, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | 1.37 Mn |
| Sep 30, 2024 | 1.37 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.37 Mn |
| Sep 30, 2023 | 1.37 Mn |